Miltamato
Category
Miltamato Brand names, Miltamato Analogs
Miltamato Brand Names Mixture
Miltamato Chemical_Formula
C20H23NS
Miltamato RX_link
No information avaliable
Miltamato fda sheet
Miltamato msds (material safety sheet)
Miltamato Synthesis Reference
No information avaliable
Miltamato Molecular Weight
309.469 g/mol
Miltamato Melting Point
< 25 oC
Miltamato H2O Solubility
Soluble as HCl salt
Miltamato State
Liquid
Miltamato LogP
5.7
Miltamato Dosage Forms
Tablets (oral, 1 mg)
Miltamato Indication
Used for the symptomatic treatment of parkinsonism.
Miltamato Pharmacology
Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.
Miltamato Absorption
Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.
Miltamato side effects and Toxicity
Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.
Miltamato Patient Information
Miltamato Organisms Affected
Humans and other mammals
